{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:49:29Z","timestamp":1792788569444,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Southern Denmark","id":[{"id":"https:\/\/ror.org\/03yrrjy16","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardio-Oncology"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with ischemic heart disease (IHD) or peripheral artery disease (PAD) represent a high-risk cardiovascular phenotype. When cancer is diagnosed in this population, clinical attention may shift toward treatment of the malignancy, potentially leading to under-recognition of pre-existing cardiovascular disease and its associated risks. Real-world data describing early cardiovascular outcomes after cancer diagnosis in this subgroup are however limited. The objective was to describe 1-year risks of cardiovascular death, major adverse cardiovascular events (MACE: ischemic stroke, systemic embolism, myocardial infarction, and hemorrhagic stroke), and venous thromboembolism (VTE: pulmonary embolism, and deep vein thromboembolism) after cancer diagnosis and to compare these risks across cancer sites within this high-risk vascular population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using nationwide Danish registries, we identified 91,253 patients with IHD and\/or PAD who developed a first primary cancer between 2002 and 2022. One-year cumulative incidences of cardiovascular death, MACE, and VTE were estimated using competing-risk methods. Multivariable Cox regression models were used to identify clinical predictors of cardiovascular outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Within one year of cancer diagnosis, 33% of patients died. The cumulative incidence of cardiovascular death was 2.4%, MACE 2.8%, and VTE 1.8%, with substantial variation across cancer types. Neurologic, respiratory, and digestive tract cancers were associated with the highest cardiovascular risk. Prior cardiovascular comorbidity strongly predicted adverse outcomes. Statin therapy was associated with lower cardiovascular mortality (hazard ratio [HR] 0.66) and fewer MACE events (HR 0.84).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Cancer patients with pre-existing IHD or PAD experience a high burden of early cardiovascular and thrombotic events with marked variation across cancer types. These findings underscore the need for integrated cardio-oncology care and support continued use of guideline-directed cardiovascular preventive therapies during cancer treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40959-026-00520-z","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T01:55:27Z","timestamp":1782957327000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiovascular risk after cancer in patients with ischemic heart disease or peripheral artery disease"],"prefix":"10.1186","volume":"12","author":[{"given":"Torben Bjerregaard","family":"Larsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricco Noel Hansen","family":"Flyckt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margrethe Bang","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus Lohman","family":"Brasen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torben Fr\u00f8strup","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flemming","family":"Skj\u00f8th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"520_CR1","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.mayocp.2014.05.013","volume":"89","author":"J Herrmann","year":"2014","unstructured":"Herrmann J, Lerman A, Sandhu NP, Villarraga HR, Mulvagh SL, Kohli M. Evaluation and management of patients with heart disease and cancer: cardio-oncology. Mayo Clin Proc. 2014;89:1287\u2013306. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25192616.","journal-title":"Mayo Clin Proc"},{"key":"520_CR2","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","volume":"37","author":"JL Zamorano","year":"2016","unstructured":"Zamorano JL, Lancellotti P, Rodriguez Mu\u00f1oz D, Aboyans V, Asteggiano R, Galderisi M, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for practice guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:2768\u2013801. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27567406.","journal-title":"Eur Heart J"},{"key":"520_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1161\/ATVBAHA.124.319863","volume":"45","author":"AAC Newman","year":"2025","unstructured":"Newman AAC, Dalman JM, Moore KJ. Cardiovascular disease and cancer: a dangerous liaison. Arterioscler Thromb Vasc Biol. 2025;45:359\u201371. Available from: https:\/\/www.ahajournals.org\/doi\/10.1161\/ATVBAHA.124.319863.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"520_CR4","doi-asserted-by":"crossref","unstructured":"Aboumsallem JP, Moslehi J, de Boer RA. Reverse cardio\u2010oncology: cancer development in patients with cardiovascular disease. J Am Heart Assoc. 2020;9. Available from: https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.119.013754.","DOI":"10.1161\/JAHA.119.013754"},{"key":"520_CR5","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon AR, L\u00f3pez-Fern\u00e1ndez T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, et al. 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022;43:4229\u2013361. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/36017568.","journal-title":"Eur Heart J"},{"key":"520_CR6","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.amjmed.2012.01.014","volume":"125","author":"PWF Wilson","year":"2012","unstructured":"Wilson PWF, D\u2019Agostino R, Bhatt DL, Eagle K, Pencina MJ, Smith SC, et al. An international model to predict recurrent cardiovascular disease. Am J Med. 2012;125:695-703.e1. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22727237.","journal-title":"Am J Med"},{"key":"520_CR7","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1136\/heartjnl-2013-303640","volume":"99","author":"JAN Dorresteijn","year":"2013","unstructured":"Dorresteijn JAN, Visseren FLJ, Wassink AMJ, Gondrie MJA, Steyerberg EW, Ridker PM, et al. Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease: the SMART risk score. Heart. 2013;99:866\u201372. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23574971.","journal-title":"Heart"},{"key":"520_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1403494810387965","volume":"39","author":"CB Pedersen","year":"2011","unstructured":"Pedersen CB. The Danish civil registration system. Scand J Public Health. 2011;39:22\u20135. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21775345.","journal-title":"Scand J Public Health"},{"key":"520_CR9","doi-asserted-by":"publisher","unstructured":"Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, S\u00f8rensen HT. The Danish National patient registry: A review of content, data quality, and research potential. Clinical Epidemiology. 2015;7:449\u201390. https:\/\/doi.org\/10.2147\/CLEP.S91125.","DOI":"10.2147\/CLEP.S91125"},{"key":"520_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/1403494810394717","volume":"39","author":"HW Kildemoes","year":"2011","unstructured":"Kildemoes HW, S\u00f8rensen HT, Hallas J. The Danish national prescription registry. Scand J Public Health. 2011;39:38\u201341. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21775349. Cited 2012 Dec 9.","journal-title":"Scand J Public Health"},{"key":"520_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/1403494811399958","volume":"39","author":"K Helweg-Larsen","year":"2011","unstructured":"Helweg-Larsen K. The Danish register of causes of death. Scand J Public Health. 2011;39:26\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21775346.","journal-title":"Scand J Public Health"},{"key":"520_CR12","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.amjmed.2018.04.042","volume":"131","author":"IE Albertsen","year":"2018","unstructured":"Albertsen IE, Nielsen PB, S\u00f8gaard M, Goldhaber SZ, Overvad TF, Rasmussen LH, et al. Risk of recurrent venous thromboembolism: a Danish nationwide cohort study. Am J Med. 2018;131:1067-1074.e4. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30266273.","journal-title":"Am J Med"},{"key":"520_CR13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u201383. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30266273.","journal-title":"J Chronic Dis"},{"key":"520_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GYH Lip","year":"2010","unstructured":"Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137:263\u201372. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19762550. Cited 2012 Oct 7.","journal-title":"Chest"},{"key":"520_CR15","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S1010-7940(03)00093-9","volume":"23","author":"V Ambrogi","year":"2003","unstructured":"Ambrogi V, Pompeo E, Elia S, Pistolese GR, Mineo TC. The impact of cardiovascular comorbidity on the outcome of surgery for stage I and II non-small-cell lung cancer. Eur J Cardiothorac Surg. 2003;23:811\u20137. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12754038.","journal-title":"Eur J Cardiothorac Surg"},{"key":"520_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0169-5002(98)00039-7","volume":"21","author":"ML Janssen-Heijnen","year":"1998","unstructured":"Janssen-Heijnen ML, Schipper RM, Razenberg PP, Crommelin MA, Coebergh JW. Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. Lung Cancer. 1998;21:105\u201313. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9829544.","journal-title":"Lung Cancer"},{"key":"520_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jacc.2022.04.042","volume":"80","author":"R Florido","year":"2022","unstructured":"Florido R, Daya NR, Ndumele CE, Koton S, Russell SD, Prizment A, et al. Cardiovascular disease risk among cancer survivors: the Atherosclerosis Risk In Communities (ARIC) study. J Am Coll Cardiol. 2022;80:22\u201332. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35772913.","journal-title":"J Am Coll Cardiol"},{"key":"520_CR18","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41569-024-01017-x","volume":"21","author":"NS Wilcox","year":"2024","unstructured":"Wilcox NS, Amit U, Reibel JB, Berlin E, Howell K, Ky B. Cardiovascular disease and cancer: shared risk factors and mechanisms. Nat Rev Cardiol. 2024;21:617\u201331. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/38600368.","journal-title":"Nat Rev Cardiol"},{"key":"520_CR19","doi-asserted-by":"publisher","first-page":"4831","DOI":"10.1093\/eurheartj\/ehad727","volume":"44","author":"FS Van Royen","year":"2023","unstructured":"Van Royen FS, Asselbergs FW, Alfonso F, Vardas P, Van Smeden M. Five critical quality criteria for artificial intelligence-based prediction models. Eur Heart J. 2023;44:4831\u20134. https:\/\/doi.org\/10.1093\/eurheartj\/ehad727.","journal-title":"Eur Heart J"},{"key":"520_CR20","first-page":"891","volume":"32","author":"H Abdel-Qadir","year":"2016","unstructured":"Abdel-Qadir H, Amir E, Thavendiranathan P. Prevention, detection, and management of chemotherapy-related cardiac dysfunction. Can J Cardiol. 2016;32:891\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27118058.","journal-title":"Can J Cardiol"},{"key":"520_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10741-018-9731-y","volume":"24","author":"PM Kostakou","year":"2019","unstructured":"Kostakou PM, Kouris NT, Kostopoulos VS, Damaskos DS, Olympios CD. Cardio-oncology: a new and developing sector of research and therapy in the field of cardiology. Heart Fail Rev. 2019;24:91\u2013100. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30073443.","journal-title":"Heart Fail Rev"},{"key":"520_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.21037\/atm.2019.11.121","volume":"8","author":"L Chen","year":"2020","unstructured":"Chen L. Overview of clinical prediction models. Ann Transl Med. 2020;8:71. Available from: http:\/\/atm.amegroups.com\/article\/view\/33251\/html.","journal-title":"Ann Transl Med"}],"container-title":["Cardio-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40959-026-00520-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-026-00520-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-026-00520-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:02:48Z","timestamp":1790078568000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40959-026-00520-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["520"],"URL":"https:\/\/doi.org\/10.1186\/s40959-026-00520-z","relation":{},"ISSN":["2057-3804"],"issn-type":[{"value":"2057-3804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"117"}}